ELISABETH SANDERSON: Open Payments
NPI 1467145367 · CRESTWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,893 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $105 |
| Teva Pharmaceuticals USA, Inc. | 5 | $102 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Corium, LLC | 5 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: INGREZZA, ARISTADA, UZEDY, Azstarys, FANAPT, COBENFY, VIVITROL, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
